Connor, Clark & Lunn Investment Management Ltd. Catalent, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$20 Billion
Q4 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$87.2 - $114.05 $802,763 - $1.05 Million	9,206 New	9,206 $988,000
Q3 2021 Nov 12, 2021	SELL	$109.17 - $142.35 $7.77 Million - $10.1 Million	-71,217 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$100.34 - $115.69 $11.9 Million - $13.7 Million	-118,132 Reduced 62.39%	71,217 $7.7 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $11.8 Million - $14.6 Million	-116,435 Reduced 38.08%	189,349 $19.9 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $10.3 Million - $12.6 Million	119,966 Added 64.56%	305,784 $31.8 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $8.89 Million - $11.3 Million	122,275 Added 192.43%	185,818 $15.9 Million
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $3.05 Million - $5.02 Million	63,543 New	63,543 $4.66 Million

Others Institutions Holding CTLT

# of Institutions

216

Shares Held

73.2M

Call Options Held

477K

Put Options Held

2.02M

Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl

4M
Shares

$254 Million
1.29% of portfolio
Balyasny Asset Management LLC Chicago, IL

3.63M
Shares

$230 Million
0.38% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account